公司資料
Glaukos Corporation 股價、新聞與催化劑
- 股票代碼:
- GKOS
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
161.42 USD (-1.25%)
收盤價
最後更新: 2026年9月17日
6.51B USD
市值
股價為何變動
截至 2026年9月17日，GKOS 下跌 1.25%，收於 $161.42。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Glaukos is a medical technology company focused on ophthalmology, glaucoma devices, and corneal health. Its business is centered on procedure-based eye-care technologies rather than therapeutics.
所在地與產業分類
Glaukos is headquartered in the United States and listed on NYSE. It sits in ophthalmic medtech rather than biotechnology.
商業模式特徵
The company depends on device adoption, surgeon acceptance, and the ability to expand across eye-care procedures. Investors watch product launches, clinical adoption, and margin trends.
生技產業定位
Glaukos occupies a high-quality ophthalmic-device niche within healthcare innovation. It is not biotech, but it is a procedure-driven growth stock with meaningful clinical relevance.
未來催化劑
- Glaukos’s catalysts are iStent / iDose commercialization, glaucoma adoption, and continued procedural growth in ophthalmology. The market will care about whether the device base keeps broadening.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。